IONIS PHARMACEUTICALS INC — Director's Dealing 2022

Jun 9, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2022-06-07

Reporting Person: BERTHELSEN SPENCER R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-07	Common Stock	M	11250	$12.94	Acquired	120899	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-07	Non-Qualified Stock Option (right to buy)	$12.94	M	11250	Disposed	2022-07-01	Common Stock (11250)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	70	Indirect

Footnotes

F1: Acquired as a result of exercising a stock option that was scheduled to expire on 7/1/2022.

F2: The reporting person disclaims beneficial ownership of all securities held by his daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.